Single-Cell Drug Screening via Droplet Partitioning and Barcoding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for single-cell drug screening and analysis are limited in their ability to efficiently process and analyze multiple drug treatments and cellular responses with high throughput and accuracy, particularly in partitioning and labeling of biological samples.
Innovation Solution
A method involving partitioning cells in separate droplets or wells, labeling them with barcode sequences, and pooling treated cells to generate barcoded nucleic acid molecules for multiplexed analysis, allowing for the tracking of cellular responses to multiple drugs and generating high-throughput data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cells are processed in separate partitions for drug screening, then measurement precision and reliability are improved, but productivity and throughput are reduced
Solution Approach 1:
The method segments the drug screening process into distinct partitions (droplets or wells), where each partition contains a single cell or small group of cells treated with specific drugs. This segmentation enables independent processing of multiple samples simultaneously, maintaining measurement precision while increasing overall throughput through parallelization of experimental conditions.
Solution Approach 2:
The method combines multiple treated cells from different partitions into pooled samples for bulk processing and analysis. By merging cells that have undergone different drug treatments into common pools, the system achieves high-throughput processing while preserving the ability to trace individual cell responses through barcode sequences, thus resolving the contradiction between precision and productivity.
2Loss of information
If barcode sequences are used to label treated cells, then information tracking is improved, but device complexity and manufacturing complexity increase
Solution Approach 1:
The method uses barcode sequences as information copies that can be amplified and detected without requiring complex physical tracking systems. Each cell's treatment history is copied into nucleic acid barcode sequences that can be replicated through PCR and detected using standard sequencing technologies, thereby maintaining information tracking capability while avoiding excessive device complexity.
Solution Approach 2:
The barcode sequencing approach serves multiple functions: it tracks drug treatment history, identifies cellular responses, and enables pooled sample analysis. This universal labeling system replaces multiple specialized tracking devices with a single molecular coding system that can be processed through standard molecular biology workflows, reducing overall system complexity.
3Productivity
If multiple drug treatments are analyzed simultaneously, then productivity is improved, but measurement precision and data analysis difficulty increase
Solution Approach 1:
The method segments different drug treatments into distinct partition groups, where each group contains cells treated with specific drug combinations. This segmentation allows simultaneous analysis of multiple treatments while maintaining clear distinction between experimental conditions, preserving measurement precision through systematic organization of high-throughput data.
Solution Approach 2:
The barcode sequences serve as intermediaries that link individual cell treatment histories to pooled sample analysis results. By using these molecular mediators, the system can simultaneously process multiple drug treatments with high throughput while maintaining the ability to accurately attribute cellular responses to specific treatment conditions, thus preserving measurement precision.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Provided herein are systems and methods for drug screening single cells from a sample. A method for drug screening may comprise treating various single cell samples with different drugs or drug combinations, labeling of treated cells with a labeling agent comprising a sample barcode, and processing the treated, labeled cells to generate nucleic acid libraries for sequencing. One or more processes of the methods described herein may be performed within a partition, such as a droplet or well.